News on the Division of Intramural Research
|
Statement
Statement from Gary H. Gibbons, M.D., Director of NHLBI: I take great pleasure in announcing that Rear Admiral Richard Childs, M.D. , has accepted the position of Scientific Director (SD) of the Division of Intramural Research (DIR), effective February 7, 2024. Childs has served as NHLBI Clinical Director since 2013 and Acting Scientific Director...
|
News Release
Researchers at the National Institutes of Health have found that a novel blood test can be used to easily evaluate disease severity in patients with pulmonary arterial hypertension (PAH) and predict survivability. PAH is a rare, life-threatening condition that causes unexplained high blood pressure in the lungs. In early clinical studies, the...
|
NHLBI in the Press
Researchers have developed a blood test that could make it possible for doctors to detect—then quickly prevent or slow down—acute heart transplant rejection, a potentially deadly condition that occurs in the early months after a patient has received a donor heart.
|
NHLBI in the Press
|
News Release
Novel imaging biomarker could track interventions on coronary artery disease Researchers have found that anti-inflammatory biologic therapies used to treat moderate to severe psoriasis can significantly reduce coronary inflammation in patients with the chronic skin condition. Scientists said the findings are particularly notable because of the use...
|
NHLBI in the Press
An increasing number of studies have linked psoriasis, a chronic inflammatory skin disease, to the development of heart disease. Now, a new study provides further evidence for this link by demonstrating how certain blood cells might interact in a way that damages blood vessels in people with this ps
|
News Release
Researchers have found that treating psoriasis, a chronic inflammatory skin disease, with biologic drugs that target immune system activity can reduce the early plaque buildup that clogs arteries, restricts blood flow, and leads to heart attacks and stroke. The findings highlight how immunotherapies that treat inflammatory conditions might play a...